000 05117nla2a2200505 4500
001 657745
005 20231030041524.0
035 _a(RuTPU)RU\TPU\network\24471
035 _aRU\TPU\network\24469
090 _a657745
100 _a20180314a2017 k y0engy50 ba
101 0 _aeng
105 _ay z 100zy
135 _adrgn ---uucaa
181 0 _ai
182 0 _ab
200 1 _aNuclear Medicine in Breast Cancer Diagnostics: Primary Tumor and Lymphatic Metastasis
_fI. G. Sinilkin, А. А. Medvedeva, V. I. Chernov [et al.]
203 _aText
_celectronic
300 _aTitle screen
320 _a[References: 24 tit.]
330 _aThe purpose of the study: to assess the possibility of using nuclear medicine techniques at the stages of diagnosis and treatment of breast cancer. Materials and Methods: The study included 290 patients with breast cancer and 70 patients with benign breast tumors. The study was used as a radiopharmaceutical 99mTc-MIBI, 199Tl for imaging tumors and colloid 99mTc-Aloteh for visualization sentinel lymph nodes (SLN), colloid was injected peritumoral in four points to 80 MBq one day prior to the planned operation. Results: The sensitivity of SPECT using both 99mTc-MIBI and 199Tl for breast cancer detection was shown to be rather high, being 98.5% and 98%, respectively. It should be noted that the sensitivity of SPECT in detection of small tumors (less than 1 cm in diameter) and multicentric tumors was not high irrespective of the radioisotope used (60% and 65% with 99mTc-MIBI and 65% and 59% with 199Tl, respectively). The difference in the sensitivity was found between 99mTc-MIBI and 199T for the detection of regional lymph node metastasis (91% vs 70%). SLN were detected in 31 patients. The most commonly SLN were defined in the axillary region of 96.7%. In 22 (70.9%) patients there was no metastasis SLN. The sensitivity of the method was 91.2%, specificity of 100%. Conclusion: The specificity of SPECT with 199Tl was higher than that with 99mTc-MIBI. The data obtained show that SPECT with 199Tl can be recommended for its use as an additional breast cancer detection method in cases when other imaging techniques and histological findings are not accurate enough. The clinical study of 99mTc-Aloteh, a new radiopharmaceutical agent, has shown that the studied colloid has high uptake level in SLN and can be successfully used for visualization of SLN in patients with breast cancer.
333 _aРежим доступа: по договору с организацией-держателем ресурса
461 0 _0(RuTPU)RU\TPU\network\4816
_tAIP Conference Proceedings
463 0 _0(RuTPU)RU\TPU\network\24427
_tVol. 1882 : Physics of Cancer: Interdisciplinary Problems and Clinical Applications (PC IPCA’17)
_oProceedings of the International conference, 23–26 May 2017, Tomsk, Russia
_fNational Research Tomsk Polytechnic University (TPU) ; eds. E. Y. Gutmanas, O. B. Naimark, Yu. P. Sharkeev
_v[020070, 5 p.]
_d2017
610 1 _aэлектронный ресурс
610 1 _aтруды учёных ТПУ
610 1 _aядерная медицина
610 1 _aдиагностика
610 1 _aрак
610 1 _aмолочные железы
610 1 _aопухоли
610 1 _aлимфатическая система
610 1 _aрадиофармацевтические препараты
610 1 _aвизуализация
701 1 _aSinilkin
_bI. G.
_cspecialist in the field of medical technology
_claboratory, Tomsk Polytechnic University, candidate of medical science
_f1972-
_gIvan Gennadjevich
_2stltpush
_3(RuTPU)RU\TPU\pers\34189
701 1 _aMedvedeva
_bА. А.
_cspecialist in the field of medical technology
_claboratory assistant of Tomsk Polytechnic University, candidate of medical science
_f1975-
_gAnna Aleksndrovna
_2stltpush
_3(RuTPU)RU\TPU\pers\37376
701 1 _aChernov
_bV. I.
_cspecialist in the field of medical technology
_clead engineer of Tomsk Polytechnic University, doctor of medical sciences
_f1962-
_gVladimir Ivanovich
_2stltpush
_3(RuTPU)RU\TPU\pers\34191
701 1 _aSlonimskaya
_bE.
701 1 _aZelchan (Zeltchan)
_bR. V.
_cspecialist in the field of medical technology
_cResearcher of the Tomsk Polytechnic University, Candidate of Medical Sciences
_f1984-
_gRoman Vladimirovich
_2stltpush
_3(RuTPU)RU\TPU\pers\34194
701 1 _aBragina
_bO. D.
_cspecialist in the field of medical technology
_cAssociate Scientist of Tomsk Polytechnic University, Candidate of medical Sciences
_f1986-
_gOlga Dmitrievna
_2stltpush
_3(RuTPU)RU\TPU\pers\35943
712 0 2 _aНациональный исследовательский Томский политехнический университет (ТПУ)
_bФизико-технический институт (ФТИ)
_bЛаборатория № 31 ядерного реактора (Лаборатория № 31 ЯР)
_h6471
_2stltpush
_3(RuTPU)RU\TPU\col\20054
801 2 _aRU
_b63413507
_c20210302
_gRCR
856 4 _uhttps://doi.org/10.1063/1.5001649
856 4 _uhttp://earchive.tpu.ru/handle/11683/46887
942 _cCF